PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-2832.32
Negative P/E while Healthcare median is -2.17. Seth Klarman would scrutinize path to profitability versus peers.
No Data
No Data available this quarter, please select a different quarter.
289.82
P/B exceeding 1.5x Healthcare median of 2.62. Jim Chanos would check for potential asset write-down risks.
-432276.02
Negative FCF while Healthcare median P/FCF is -14.60. Seth Klarman would investigate cash flow improvement potential.
-432276.02
Negative operating cash flow while Healthcare median P/OCF is -5.71. Seth Klarman would investigate operational improvement potential.
289.82
Fair value ratio exceeding 1.5x Healthcare median of 2.61. Jim Chanos would check for valuation bubble risks.
-0.01%
Negative earnings while Healthcare median yield is -0.20%. Seth Klarman would investigate path to profitability.
-0.00%
Negative FCF while Healthcare median yield is -0.23%. Seth Klarman would investigate cash flow improvement potential.